Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 205 (RNA5SP205) is a processed pseudogene derived from the 5S ribosomal RNA gene family[2][5]. Unlike functional 5S rRNA genes, which play an essential structural and regulatory role in the large ribosomal subunit across all domains of life[1][3], RNA5SP205 has lost its capacity to encode a functional RNA, likely due to mutations or truncations disrupting its transcription or RNA folding[6]. Processed pseudogenes such as RNA5SP205 typically arise through retrotransposition events and are generally regarded as "genetic fossils," integrated into the genome but lacking biological activity[6]. There is no evidence to suggest that RNA5SP205 is involved in disease, interacts with drugs, serves as a biomarker, or poses safety or therapeutic concerns. Summary of Core Points: - This entity is a pseudogene, not a functional ribosomal RNA or therapeutic target. - It is not suitable for drug targeting, mechanism-of-action, or biomarker use. - There is no evidence of disease relevance or functional biology beyond being a genomic remnant of ribosomal RNA evolution and retrotransposition.[2][5][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 205 (RNA5SP205).